tiprankstipranks
CytoMed Therapeutics Limited (GDTC)
NASDAQ:GDTC
US Market
GDTC
CytoMed Therapeutics Limited
RESEARCH TOOLSreports
Want to see GDTC full AI Analyst Report?

CytoMed Therapeutics Limited (GDTC) Revenue

23 Followers
StatisticsMarket CapRevenue

CytoMed Therapeutics Limited Revenue

CytoMed Therapeutics Limited had a revenue of 130.63K in the quarter ending Dec 31, 2025, with 23.58%. This bring the company's revenue in the last twelve months to 336.37K, Increased -8.29%. In the fiscal year ending Dec 31, 2025, CytoMed Therapeutics Limited had annual revenue of 248.27K with 377.39% growth.
Revenue (ttm)
336.37K
Revenue Growth
373.88%
P/S Ratio
46.40
Revenue/Employee
$5,774
Employees
43
Market Cap
$11.52M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
248.27K196.26K+377.39%
Dec 31, 2024
52.01K-238.56K-82.10%
Mar 31, 2024
290.56K―+∞%
Dec 31, 2022
―-84.18K-100.00%
Dec 31, 2021
84.18K39.26K+87.38%
Dec 31, 2020
44.92K―+∞%
Dec 31, 2019
―――